Last reviewed · How we verify
Moderately severe pneumonia
Approved treatments
- Bicillin C-R · Pfizer Inc.
Penicillin G inhibits bacterial cell-wall peptidoglycan biosynthesis, rendering the cell wall osmotically unstable.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Moderately severe pneumonia patent landscape — cliff calendar, originator estates, attackable patents
- Moderately severe pneumonia treatment landscape brief
- Moderately severe pneumonia treatment updates RSS
Frequently asked questions about Moderately severe pneumonia
What drugs treat Moderately severe pneumonia?
Tracked treatments include Bicillin C-R.
What is the treatment for Moderately severe pneumonia?
Standard treatment for Moderately severe pneumonia includes Bicillin C-R. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Moderately severe pneumonia patent cliff · Moderately severe pneumonia CI report
- Treatment: Bicillin C-R · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing